Predicting Incident Radiographic Knee Osteoarthritis in Middle-Aged Women Within Four Years: The Importance of Knee-Level Prognostic Factors.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
01 2020
Historique:
received: 11 10 2018
accepted: 21 05 2019
pubmed: 28 5 2019
medline: 12 5 2020
entrez: 26 5 2019
Statut: ppublish

Résumé

To develop and internally validate risk models and a clinical risk score tool to predict incident radiographic knee osteoarthritis (RKOA) in middle-aged women. We analyzed 649 women in the Chingford 1,000 Women study. The outcome was incident RKOA, defined as Kellgren/Lawrence grade 0-1 at baseline and ≥2 at year 5. We estimated predictors' effects on the outcome using logistic regression models. Two models were generated. The clinical model considered patient characteristics, medication, biomarkers, and knee symptoms. The radiographic model considered the same factors, plus radiographic factors (e.g., angle between the acetabular roof and the ilium's vertical cortex [hip α-angle]). The models were internally validated. Model performance was assessed using calibration and discrimination (area under the receiver characteristic curve [AUC]). The clinical model contained age, quadriceps circumference, and a cartilage degradation marker (C-terminal telopeptide of type II collagen) as predictors (AUC = 0.692). The radiographic model contained older age, greater quadriceps circumference, knee pain, knee baseline Kellgren/Lawrence grade 1 (versus 0), greater hip α-angle, greater spinal bone mineral density, and contralateral RKOA at baseline as predictors (AUC = 0.797). Calibration tests showed good agreement between the observed and predicted incident RKOA. A clinical risk score tool was developed from the clinical model. Two models predicting incident RKOA within 4 years were developed, including radiographic variables that improved model performance. First-time predictor hip α-angle and contralateral RKOA suggest OA origins beyond the knee. The clinical tool has the potential to help physicians identify patients at risk of RKOA in routine practice, but the tool should be externally validated.

Identifiants

pubmed: 31127870
doi: 10.1002/acr.23932
pmc: PMC6935374
mid: EMS84849
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-97

Subventions

Organisme : Medical Research Council
ID : MC_U147585827
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585819
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A620_1014
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : 21595
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585824
Pays : United Kingdom

Informations de copyright

© 2019, American College of Rheumatology.

Références

Ann Rheum Dis. 1995 Sep;54(9):721-5
pubmed: 7495342
Arthritis Rheum. 1997 Apr;40(4):728-33
pubmed: 9125257
BMJ Open. 2013 Mar 01;3(3):null
pubmed: 23457332
Ann Rheum Dis. 2011 Sep;70(9):1599-604
pubmed: 21613308
QJM. 2006 Oct;99(10):673-82
pubmed: 16998210
Bone. 2005 Oct;37(4):446-56
pubmed: 16027057
Osteoarthritis Cartilage. 2016 Dec;24(12):2100-2107
pubmed: 27390031
Ann Rheum Dis. 1958 Dec;17(4):388-97
pubmed: 13606727
Arthritis Care Res (Hoboken). 2012 Jun;64(6):881-9
pubmed: 22232080
Arthritis Rheum. 2012 Jul;64(7):2243-51
pubmed: 22422507
Nat Rev Rheumatol. 2013 Apr;9(4):225-35
pubmed: 23247649
J Clin Epidemiol. 2010 Feb;63(2):205-14
pubmed: 19596181
Osteoarthritis Cartilage. 2014 May;22(5):683-9
pubmed: 24576742
Arthritis Rheum. 2002 Oct;46(10):2613-24
pubmed: 12384919
Arthritis Rheum. 2000 May;43(5):995-1000
pubmed: 10817551
Arthritis Rheum. 2003 Nov;48(11):3112-7
pubmed: 14613273
Osteoarthritis Cartilage. 2010 Jan;18(1):24-33
pubmed: 19751691
Arthritis Rheum. 2011 Nov;63(11):3392-400
pubmed: 21739424
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
J Med Life. 2014 Mar 15;7(1):37-41
pubmed: 24653755
Arthritis Rheum. 1996 Jan;39(1):81-6
pubmed: 8546742
Curr Rheumatol Rep. 2014 Nov;16(11):463
pubmed: 25240686
Ann Intern Med. 2015 Jan 6;162(1):W1-73
pubmed: 25560730
Ann Rheum Dis. 2014 Sep;73(9):1659-64
pubmed: 23744977
BMC Med Res Methodol. 2007 Jul 13;7:33
pubmed: 17629912
Rheumatology (Oxford). 2016 Mar;55(3):495-503
pubmed: 26467750
Ann Rheum Dis. 2014 Dec;73(12):2116-21
pubmed: 23962456
Arthritis Rheum. 1999 May;42(5):861-70
pubmed: 10323441
Osteoarthritis Cartilage. 2010 May;18(5):601-4
pubmed: 20175975
BMC Musculoskelet Disord. 2008 Dec 12;9:163
pubmed: 19077272
Ann Rheum Dis. 1993 Nov;52(11):790-4
pubmed: 8250610
Osteoarthritis Cartilage. 2015 Apr;23(4):507-15
pubmed: 25447976
Ann Rheum Dis. 2010 Jan;69(1):163-8
pubmed: 19147619
J Bone Joint Surg Am. 2010 Oct 20;92(14):2436-44
pubmed: 20962194
Arthritis Rheum. 2002 Jan;46(1):92-9
pubmed: 11817613
Bone. 2015 Feb;71:171-9
pubmed: 25445455
Arthritis Rheum. 1999 Jan;42(1):17-24
pubmed: 9920009
Ann Rheum Dis. 2014 Jul;73(7):1323-30
pubmed: 24553908
Joint Bone Spine. 2012 May;79(3):291-7
pubmed: 21803633
Arthritis Rheum. 1995 Aug;38(8):1134-41
pubmed: 7639811
J Sci Med Sport. 2015 Mar;18(2):122-7
pubmed: 24702945
Ann Rheum Dis. 2014 Aug;73(8):1442-5
pubmed: 24625626

Auteurs

Cesar Garriga (C)

University of Oxford, Oxford, UK.

Maria T Sánchez-Santos (MT)

University of Oxford, Oxford, UK.

Andrew Judge (A)

University of Oxford, Oxford, University of Southampton and Southampton General Hospital, Southampton, and Bristol Medical School, University of Bristol, and Southmead Hospital, Bristol, UK.

Deborah Hart (D)

King's College London, London, UK.

Tim Spector (T)

King's College London, London, UK.

Cyrus Cooper (C)

University of Oxford, Oxford, and University of Southampton and Southampton General Hospital, Southampton, UK.

Nigel K Arden (NK)

University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH